|
|
 |
|
Viewing report
|
|
|
Biotech Company Outlook to 2016
Datamonitor, Nov 2011, Pages: 45
This analysis examines the outlook for companies in the Biotech peer set. The report encompasses insight into key strategic themes across the group of companies and identifies sales trends using 6-year prescription pharmaceutical sales forecasts for all the companies covered.
Features and benefits
- Gain insight into Biotech companies strategic outlook across the next 6 years
- Analyze sales forecasts by company, therapy area, lifecycle stage, and molecule type.
Highlights
Strategic insight into the prospects for Biotech companies over the next six years. Picking out key trends across the companies and comparing performance using a variety of cuts of forecast sales.
Your key questions answered
- Benchmark companies outlook against key rivals across the Biotech peer set
- Analyze how peer set sales attributable to therapeutic proteins will come under increased threat from biosimilar competition through to 2016
|
|
|
|
